Clinical Trial Update: An 8-week Study to Evaluate Safety and Efficacy of NGF Eye Drops Solution Versus Vehicle in Patients With Dry Eye [Phase 2]

View source ↗

Summary

Phase 2, an 8-week study evaluating safety and efficacy of nerve growth factor eye drops (cenegermin) vs vehicle in dry eye was completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Oxervate (cenegermin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2019-02-08